Search Results - Alexey V. Danilov

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial

    Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial by Alexey V. Danilov, Hongli Li, Mazyar Shadman, Lisa Rimsza, Ahmad Zebari, Sonali M. Smith, Michael LeBlanc, Jonathan W. Friedberg, Christopher Carlson, Joo Y. Song

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter’s transformation or transformed non-Hodgkin lymphoma: results from a phase I trial

    Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter’s transformation or transformed non-Hodgkin lymphoma: results from a phase I trial by Geoffrey Shouse, Canping Chen, Alexandra Muir, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Alex F. Herrera, Olga Danilova, Carly Roleder, Lili Wang, Stephen E.F. Spurgeon, Adam S. Kittai, Lu Chen, Zheng Xia, Matthew S. Davids, Alexey V. Danilov

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: